For the year ending 2025-12-31, GEHC had $1,623M increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income from continuing operations | 2,154 | 2,050 | 1,618 |
| Depreciation of property, plant, and equipment | 287 | 268 | 248 |
| Amortization of intangible assets | 291 | 312 | 362 |
| Gain on fair value remeasurement of contingent consideration | - | -19 | -17 |
| Gain on remeasurement of nihon medi-physics equity method investment | 97 | - | - |
| Net periodic postretirement benefit plan (income) expense | -267 | -357 | -332 |
| Postretirement plan contributions | 338 | 332 | 357 |
| Share-based compensation | 130 | 125 | 114 |
| Provision for income taxes | 614 | 531 | 743 |
| Cash paid during the year for income taxes | 429 | 491 | 474 |
| Receivables | 216 | 178 | 185 |
| Due from related parties | - | -25 | -4 |
| Inventories | 142 | 81 | -111 |
| Contract and other deferred assets | 60 | -3 | -10 |
| Accounts payable | 90 | 126 | -13 |
| Due to related parties | - | -61 | -84 |
| Contract liabilities | 81 | 68 | 26 |
| Current compensation and benefits | 94 | 39 | - |
| All other operating activities net | -204 | -74 | 327 |
| Cash from (used for) operating activities continuing operations | 1,987 | 1,955 | 2,101 |
| Additions to property, plant and equipment and internal-use software | 482 | 401 | 387 |
| Dispositions of property, plant, and equipment | 0 | 0 | 1 |
| Purchases of businesses, net of cash acquired | 378 | 313 | 147 |
| Purchases of investments | 118 | 40 | - |
| All other investing activities net | 69 | 160 | 25 |
| Cash from (used for) investing activities continuing operations | -1,047 | -914 | -558 |
| Net increase (decrease) in borrowings (maturities of 90 days or less) | 1 | 0 | -12 |
| Newly issued debt, net of debt issuance costs (maturities longer than 90 days) | 2,734 | 995 | 2,006 |
| Repayments and other reductions (maturities longer than 90 days) | 1,767 | 1,418 | 855 |
| Dividends paid to stockholders | 64 | 55 | 41 |
| Repurchase of common stock | 200 | - | - |
| Redemption of noncontrolling interests | 0 | 0 | 211 |
| Net transfers (to) from ge | 0 | 0 | -1,317 |
| Proceeds from stock issued under employee benefit plans | 37 | 33 | - |
| Taxes paid related to net share settlement of equity awards | 42 | 93 | - |
| All other financing activities net | -81 | -34 | -48 |
| Cash from (used for) financing activities continuing operations | 617 | -573 | -478 |
| Cash from (used for) operating activities discontinued operations | 0 | -4 | 0 |
| Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash | 66 | -77 | -10 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 1,623 | 387 | 1,055 |
| Cash and cash equivalents at beginning of period | 2,893 | 2,506 | 1,451 |
| Cash and cash equivalents at end of period | 4,515 | 2,893 | 2,506 |
GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC)